C. G. Shchokina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
C. G. Shchokina has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- A. L. Shtroblya
Uzhgorod National University, Uzhgorod, Ukraine
1 shared publication D. V. Semeniv
Ivano-Frankivsk National Medical University
1 shared publication- I. V. Kireyev
Institute for Advanced Training of Pharmacy Specialists, The National University of Pharmacy, 61002 Kharkiv, Ukraine
1 shared publication - L. B. Ivantsyk
National University of Pharmacy, Ministry of Public Health of Ukraine, Kharkiv, Ukraine
1 shared publication - N. M. Seredynska
Institute of Pharmacology and Toxicology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
1 shared publication - S. M. Drogovoz
National University of Pharmacy, Ministry of Public Health of Ukraine, Kharkiv, Ukraine
1 shared publication
Latest Publications
- 1 January 2021
- Published by Springer Nature in Neurophysiology
- Vol. 53 (1) , 56-64
Analgesic Action of Invasive Carboxytherapy: Mechanisms and Applications
- 1 January 2021
- Published by Springer Nature in Neurophysiology
- Vol. 53 (1) , 56-64
Analgesic Action of Invasive Carboxytherapy: Mechanisms and Applications
- Open Access
- 14 September 2017
- Published by National University of Pharmacy in Clinical pharmacy
- Vol. 21 (3) , 41-45
The effect of thick burdock extracts on development of model hyperplasia of the prostate gland in rats
Benign prostatic hyperplasia (BPHP) is one of the most common diseases in middle-aged and elderly men. In this regard, the search and study of new effective and safe medicines with the prostatoprotective effect is important and topical. For today, the nomenclature of domestic protostatotectors of the plant origin is limited. Aim. To study experimentally the protoprotective properties of thick extracts of roots and leaves of common burdock on the model of sulpiride-induced prostatic hyperplasia in rats. Materials and methods. The BPHP model reproduced the intraperitoneal administration of sulpiride to male rats in the dose of 40 mg/kg for 30 days. Thick burdock extracts in the dose of 75 mg/kg and the reference drug Prostaplant Forte in the dose of 35 mg/kg were administered intraperitoneally in the therapeutic regimen from day 31 to day 52 of the study. Results. It has been proven that thick extracts of roots and leaves of burdock on the model of sulpiride-induced benign prostatic hyperplasia in rats reduce development of inflammatory processes, inhibit the processes of LPO, normalize the antioxidant / prooxidant balance in the animal’s body. Under the influence of these extracts the level of androgenic saturation of the body and the testosterone/estradiol ratio increase, indicating a positive effect of drugs on spermatogenesis. Thick extracts of burdock roots and leaves reduce the level of estradiol and dihydrotestosterone in the blood serum of the experimental animals, and it impedes development of proliferative processes in the prostate and inhibits development of the disease. Conclusions. By the intensity of the prostatoprotective action thick extracts of roots and leaves of common burdock are not inferior to the reference drug Prostaplant Forte.
- 14 September 2017
- Published by National University of Pharmacy in Clinical pharmacy
- Vol. 21 (3) , 41-45
Open AccessThe effect of thick burdock extracts on development of model hyperplasia of the prostate gland in rats
Benign prostatic hyperplasia (BPHP) is one of the most common diseases in middle-aged and elderly men. In this regard, the search and study of new effective and safe medicines with the prostatoprotective effect is important and topical. For today, the nomenclature of domestic protostatotectors of the plant origin is limited. Aim. To study experimentally the protoprotective properties of thick extracts of roots and leaves of common burdock on the model of sulpiride-induced prostatic hyperplasia in rats. Materials and methods. The BPHP model reproduced the intraperitoneal administration of sulpiride to male rats in the dose of 40 mg/kg for 30 days. Thick burdock extracts in the dose of 75 mg/kg and the reference drug Prostaplant Forte in the dose of 35 mg/kg were administered intraperitoneally in the therapeutic regimen from day 31 to day 52 of the study. Results. It has been proven that thick extracts of roots and leaves of burdock on the model of sulpiride-induced benign prostatic hyperplasia in rats reduce development of inflammatory processes, inhibit the processes of LPO, normalize the antioxidant / prooxidant balance in the animal’s body. Under the influence of these extracts the level of androgenic saturation of the body and the testosterone/estradiol ratio increase, indicating a positive effect of drugs on spermatogenesis. Thick extracts of burdock roots and leaves reduce the level of estradiol and dihydrotestosterone in the blood serum of the experimental animals, and it impedes development of proliferative processes in the prostate and inhibits development of the disease. Conclusions. By the intensity of the prostatoprotective action thick extracts of roots and leaves of common burdock are not inferior to the reference drug Prostaplant Forte.
- Open Access
- 10 June 2014
- Published by National University of Pharmacy in Clinical pharmacy
- Vol. 18 (2) , 17-21
The influence of recombinant antagonist interleukin-1 receptors on the course of tetrachloromethane hepatitis in rats
The influence of recombinant antagonist interleukin-1 receptors on the course of tetrachloromethane hepatitis in rats
- 10 June 2014
- Published by National University of Pharmacy in Clinical pharmacy
- Vol. 18 (2) , 17-21
Open AccessThe influence of recombinant antagonist interleukin-1 receptors on the course of tetrachloromethane hepatitis in rats
The influence of recombinant antagonist interleukin-1 receptors on the course of tetrachloromethane hepatitis in rats